Actar – Idea-to-innovation tool for reseachers

Actar is a drug discovery company based on the Karolinska Institutet campus at Stockholm, Sweden. The company is a part of Karolinska Institutet´s innovation system.

 Actar explores innovative drug targets in multiple therapeutic areas resulting from academic research at top European institutions. Actar collaborates with the academic researchers to perform drug discovery based on these targets. Aiming to discover proprietary compounds with validated effect in relevant disease models, Actar brings its expertise in drug research and project management together with therapeutic area competency of the academic researchers. Drug-like compounds active against these targets are identified, characterized and divested, or further developed in collaboration with larger pharmaceutical companies. 

About High-throughput Screening (HTS)

HTS allows us to effectively test a large number of chemical compounds in a short period of time through a combination of modern robotics, data processing and innovative assays. Through HTS we can rapidly identify active compounds that modulate a particular biological pathway. The results of these experiments provide a starting point for drug development.

Purpose of HTS at Actar AB

The purpose of HTS is to identify active compounds that target your molecule of interest. This will generate commercial possibilities to transform your academic research into clinical drugs. Furthermore, the identification of active compounds will add new possibilities to your academic research.

Actar is open to reserchers from all academic institutions, and is continuosly looking for new projects. The process for assessing, incorporating new projects is described under the headings to the left.

We look forward to a rewarding collaboration with you!